amantadine and chronic COVID syndrome studies

amantadine and chronic COVID syndrome

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Research Excerpts

Excerpt	Relevance	Reference
"Amantadine has complex activity including antiviral, antiinflammatory and dopaminergic effects."	1.72	The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design. ( Bonek, R; Chełstowski, W; Dąbrowski, P; Dec, M; Fiedor, P; Gala-Błądzińska, A; Goch, A; Grieb, P; Kiciak, S; Król, ZJ; Papuć, E; Rejdak, K; Segiet, A; Zasybska, A; Łukasiak, J, 2022)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

2 (100.00)

2.80

Authors

Authors	Studies
Rejdak, K	1
Fiedor, P	1
Bonek, R	1
Goch, A	1
Gala-Błądzińska, A	1
Chełstowski, W	1
Łukasiak, J	1
Kiciak, S	1
Dąbrowski, P	1
Dec, M	1
Król, ZJ	1
Papuć, E	1
Zasybska, A	1
Segiet, A	1
Grieb, P	1
Müller, T	1
Riederer, P	1
Kuhn, W	1

Studies

Rejdak, K

Fiedor, P

Bonek, R

Goch, A

Gala-Błądzińska, A

Chełstowski, W

Łukasiak, J

Kiciak, S

Dąbrowski, P

Dec, M

Król, ZJ

Papuć, E

Zasybska, A

Segiet, A

Grieb, P

Müller, T

Riederer, P

Kuhn, W

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus[NCT04854759]	Phase 3	200 participants (Anticipated)	Interventional	2021-03-15	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus[NCT04854759]

Phase 3

200 participants (Anticipated)

Interventional

2021-03-15

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for amantadine and chronic COVID syndrome

Article	Year
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design. Contemporary clinical trials, 2022, Volume: 116 Topics: Amantadine; COVID-19; COVID-19 Drug Treatment; Humans; Post-Acute COVID-19 Syndrome; Respiratory Ins	2022
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome? Expert review of clinical pharmacology, 2023, Volume: 16, Issue:2 Topics: Alzheimer Disease; Amantadine; COVID-19; Humans; Memantine; Parkinson Disease; Post-Acute COVID-19 S	2023

Article

Year

The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design.

Contemporary clinical trials, 2022, Volume: 116

Topics: Amantadine; COVID-19; COVID-19 Drug Treatment; Humans; Post-Acute COVID-19 Syndrome; Respiratory Ins

2022

Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?

Expert review of clinical pharmacology, 2023, Volume: 16, Issue:2

Topics: Alzheimer Disease; Amantadine; COVID-19; Humans; Memantine; Parkinson Disease; Post-Acute COVID-19 S

2023